Anti-counterfeiting

Combating global threat with precision technology

Counterfeit pharmaceuticals are one of the most critical issues facing the industry today, dramatically impacting the quality and costs of healthcare globally. The World Health Organization estimates that up to 1% of drug sales are counterfeit in developed countries, but the figure rises substantially in underdeveloped countries. In addition, over 50% of medicines purchased over the Internet from illegal sites that conceal their physical address have been found to be counterfeit. 

To eliminate the threat of counterfeit medications, governments and industry groups around the globe have been passing and reviewing legislation to prompt action that will secure the supply chain worldwide. Several US states are reviewing “ePedigree” laws that would require manufacturers and distributors to provide electronic records of sale for each drug unit.

As the industry moves towards implementing technology to support ePedigree, we stand ready with proven track-and-trace solutions. Rather than merely reacting to the industry issues surrounding counterfeiting, our packaging services business has been proactive in planning, implementing, and evaluating technologies and procedures to combat this critical problem.

Catalent Benefits

• Ensure your products’ purity and your brand’s reputation 
• Counteract the dramatic impact counterfeit products have on the quality and costs of healthcare globally
• Uniquely track and trace your products through chain of custody - from manufacturers to distributors to pharmacies and hospitals

Valuable Product Differentiation

An early adopter of track-and-trace solutions, Catalent remains on the cutting edge of anti-counterfeiting technology:  

• Radio Frequency Identification Technology (RFID) 
  • We manufacture RFID-enabled labels for pharmaceutical manufacturers as well as tag and encode products with item-specific data at our major packaging facilities.
• Overt and covert authentication solutions 
  • We incorporate novel anti-counterfeiting features into the secondary packaging of drugs. 
    • Overt: features that allow consumers to confirm the authenticity of products themselves
    • Covert: features that allow supply chain partners and manufacturers to verify product authenticity with specialized equipment

Facilities

All of our sites are subject to annual review so we can remain in compliance with:

• FDA/cGMP
• Canadian HPB
• British MHRA
• European community
• Brazilian authorities